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Abstract
Deoxyribonucleic acid (DNA) of the human immunodeficiency virus (HIV) provides the most sensitive measurement of
residual infection in patients on effective combination antiretroviral therapy (cART). Droplet digital PCR (ddPCR) has recently
been shown to provide highly accurate quantification of DNA copy number, but its application to quantification of HIV DNA,
or other equally rare targets, has not been reported. This paper demonstrates and analyzes the application of ddPCR to
measure the frequency of total HIV DNA (pol copies per million cells), and episomal 2-LTR (long terminal repeat) circles in
cells isolated from infected patients. Analysis of over 300 clinical samples, including over 150 clinical samples assayed in
triplicate by ddPCR and by real-time PCR (qPCR), demonstrates a significant increase in precision, with an average 5-fold
decrease in the coefficient of variation of pol copy numbers and a .20-fold accuracy improvement for 2-LTR circles.
Additional benefits of the ddPCR assay over qPCR include absolute quantification without reliance on an external standard
and relative insensitivity to mismatches in primer and probe sequences. These features make digital PCR an attractive
alternative for measurement of HIV DNA in clinical specimens. The improved sensitivity and precision of measurement of
these rare events should facilitate measurements to characterize the latent HIV reservoir and interventions to eradicate it.
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Introduction
Exponential amplification of nucleic acids by the polymerase
chain reaction (PCR) is the cornerstone of modern molecular
biology. Numerous methods have been developed to obtain
quantitative information from PCR about the concentration of
deoxyribonucleic acid (DNA) before amplification. The most
widely used form of quantitative PCR (qPCR) is ‘‘real-time’’ PCR
(qPCR), in which initial concentrations are extrapolated from
sequential measurements during the cycling reaction [1]. Digital
PCR (dPCR) [2], in which the amplification reaction is divided
into thousands of microscopic reaction volumes, is a rapidly
growing alternative that is potentially more accurate [3,4,5] and
more precise [6,7]. This paper focuses on the application of
droplet digital PCR (ddPCR) [8], in which micro-partitioning is
achieved by emulsification of the aqueous PCR reaction mixture
in a thermostable oil.
Few fields have been more profoundly impacted by quantitative
PCR than virology. The quantification and dynamics of HIV
burden in infected patient were originally elucidated using
quantitative PCR to measure viral ribonucleic acid (RNA) in
blood plasma [9,10],[9,10] and viral load testing remains the
standard clinical tool to assess the rate of disease progression.
Combination antiretroviral therapy now results in suppression of
plasma viremia below the level of detection of commercial assays
in most treated patients, but HIV nucleic acids remain important
indicators of residual infection in these patients. Proviral HIV
DNA is the most widely used measure of cellular reservoir size,
and other forms, including 2-LTR (long terminal repeat) circles
and cell-associated RNA and DNA, provide additional informa-
tion about viral dynamics.
Measurement of HIV DNA in translational research studies has
relied upon a variety of home-brew assays [11,12,13], primarily
based on real-time PCR [14,15,16]. Despite the importance of
quantitative PCR assays in HIV research, the impact of assay
variability is often ignored or underestimated. Both qPCR and
most terminal dilution methods effectively measure logarithmic
copy number. This approach improves dynamic range at the
expense of accuracy and linearity [17]. Subtraction of measured
values, often performed implicitly in longitudinal analyses or when
comparing different DNA forms, further degrades the signal-to-
noise ratio. This has resulted in data that are difficult to compare
between studies, and at worst may be not robust or not informative
due to dominant assay noise.
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This paper describes an assay for HIV pol and 2-LTR circles in
human peripheral blood samples based on droplet digital PCR.
The assay relies on well-established biochemistry, using primer sets
and TaqMan hydrolysis probes published previously [18,19].
Quantitative benefits and limitations of this assay are analyzed and
compared with a real-time PCR assay using identical primer/
probe sets to illustrate the intrinsic advantages and limitations of
these two assay formats.
Materials and Methods
Cell Samples
‘‘Clinical samples’’ of HIV-1 seropositive patients analyzed had
been previously collected in ongoing research studies approved by
the applicable Institutional Review Boards at Brigham and
Women’s Hospital, Johns Hopkins University, the University of
North Carolina, Chapel Hill, and the University of California, San
Francisco. The authors were blinded to patient data for these
samples. The cohorts from which these samples had been drawn
were known. Most of these samples (.95%) were peripheral blood
mononuclear cells, and the remainder consisted of purified CD4+
T cells. Purification of these CD4+ T cells had been performed at
the collection site, and thus purification methods were not known.
‘‘PBMC samples’’ were extracted from the blood of HIV-
negative healthy donors at the University of California San Diego
(UCSD). All subjects gave written, informed consent and blood
collection protocols were approved by the UCSD Institutional
Review Board. Peripheral blood mononuclear cells (PBMC) were
purified from whole blood with Lymphoprep, following the
manufacturer’s recommended protocol.
‘‘Infected CD4+ T cells’’ were purified from blood collected
identically using a RosetteSep (StemCell Technologies) CD4+ T
Negative Isolation Kit. Purified CD4 cells were incubated
overnight prior to activation with surface-bound anti-CD3/anti-
CD28 and infected with NL4-3 at a multiplicity of infection of 0.2.
Two days after infection, cells were washed and cryo-preserved
until DNA extraction.
DNA Extraction and Digestion
Cellular DNA was extracted using a Qiagen DNA Blood Midi
Kit, following the manufacturer’s protocol. In all cases, DNA was
ethanol precipitated following elution to increase concentration.
The DNA concentration was estimated from the A260/A280
absorptivity ratio using a NanoDrop 2000 spectrophotometer
(Thermo Scientific). When the DNA concentration was below the
desired concentration for emulsification, the concentration was
increased by ethanol precipitation and re-suspension. Where
specified, templates were thoroughly mixed with background
human genomic DNA obtained by identical extraction methods
from HIV seronegative donors (‘‘PBMC DNA’’) or with sonicated
salmon sperm DNA (Agilent Technologies).
Extracted DNA was heated to 95uC for 10 minutes then
quenched on ice prior to digest with the restriction enzyme BSAJ-I
(New England Biolabs) at 60uC for 1 hour.
DNA Standards
Plasmids encoding the entire HIV genome (pNL4-3, AIDS
Reference Research Reagent Repository) or a 2-LTR junction (a
kind gift from Dr. Kristine Yoder, Ohio State University) were
used as standards for qPCR.
PCR Primers and Probes
Both real-time and digital PCR reactions used published
primers to conserved regions of HIV pol (Hxb2 positions 2536–
2662) [19] and to the HIV LTR (Hxb2 positions 9585–51) [18].
For real-time-PCR, genomic quantification used TaqMan Ribo-
nuclease P (RNase P) Control Reagents (Life Technologies). For
ddPCR, an RPP30 (RNAse P) primer/probe set was used for host
genomic DNA quantification. Samples were diluted 10-fold and
RPP30 was assayed without multiplexing. Primers and probes are
listed in Table S1.
Real-Time PCR
Real-time PCR reactions were performed in a 50 mL solution
containing 25 mL PerfeCTa Multiplex Master Mix containing
ROX (Quanta Biosciences), 900 nM primers, 250 nM probe, and
1 mg of template DNA. Reactions were conducted in triplicate.
Cycling proceeded in an Applied Biosystems 7900HT Sequence
Detection System with the following parameters: 50uC for
2 minutes, 95uC for 10 minutes, followed by 50 cycles of 95uC
for 15 seconds and 60uC for 1 minute. A standard curve of pNL4-
3 plasmid DNA in triplicate, 10-fold serial dilutions was included
on each plate. PCR reactions used FAM-labeled pol probes
multiplexed with VIC-labeled RNAse P for genomic DNA
quantification, together with the corresponding forward and
reverse primers. A FAM-labeled 2-LTR probe and 2-LTR
primers were used in a separate reaction for each sample.
Digital PCR
The PCR reaction mixture was loaded into the Bio-Rad QX-
100 emulsification device and droplets were formed following the
manufacturer’s instructions. The contents were transferred to a
96-well reaction plate and sealed with a pre-heated Eppendorf 96-
well heat sealer for 2 seconds, as recommended by Bio-Rad.
Total DNA was amplified separately in an Applied Biosystems
GeneAmp 9700 thermal cycler. Each reaction consisted of a
20 mL solution containing 10 mL ddPCR Probe Supermix,
900 nM primers, 250 nM probe, and template DNA with the
following cycling conditions: 10 minutes at 95uC, 40 cycles each
consisting of a 30 second denaturation at 94uC followed by a 58uC
extension for 60 seconds, and a final 10 minutes at 98uC. After
cycling droplets were analyzed immediately or stored at 4uC
overnight and until analysis.
Data Analysis
Raw fluorescence data for each well were exported from the
manufacturer’s software (Bio-Rad QuantaSoft v. 1.2) for analysis.
Analysis of individual event data was performed using custom
software written in Mathematica 8.0 (Wolfram Research).
Droplets were classified as positive, negative or ambiguous
following a custom algorithm that filters out potentially spurious
events. (Fig. S5) Events that remained ambiguous after all data
processing were excluded.
The number of template copies per unit volume m was estimated
from the number of positive events n detected in the corresponding
channel and the number of total accepted droplets N by maximum
likelihood. The distribution of templates within a drop was
assumed to follow a Poisson distribution, and the number of
positive droplets was assumed to follow a binomial distribution.
Confidence intervals were estimated under the same assumptions.
The droplet size was assumed to be 0.91 nl, consistent with the
instrument manufacturer’s software.
Template copies per sample were computed by averaging over
all available replicate wells. Total cellular DNA input was
measured by halving the estimated number of RPP30 copies,
and copy numbers per diploid cell equivalent were computed as
the ratio of template (pol or 2-LTR) copies per diploid cell.
Measurement of HIV DNA by Droplet Digital PCR
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Statistical analyses were performed using Graph-Pad Prism 5.0
software (GraphPad Software, Inc.) and Mathematica 8.0.
Results
It was desirable to load as much DNA as possible into each well
to maximize assay sensitivity, because the HIV targets of interest
are extremely rare amidst a large background of host cellular
DNA. To determine the maximum amount of cellular DNA that
could be loaded into a single well, 10, 100 or 1000 copies of pNL4-
3 or 2-LTR plasmid were spiked into a background of salmon
sperm DNA prior to droplet formation (Fig. 1). Measured copy
numbers did not vary significantly when up to 1 mg of background
cellular DNA was loaded. A sharp decrease in measured copy
numbers was noted when more than 1.5 mg was loaded per well,
consistent with inhibition of PCR amplification. When more than
3 mg was loaded into a single well, the number of droplets formed
decreased. In some cases, gross deformation of formed droplets
was visible to the naked eye. Based on these results, subsequent
experiments loaded 1 mg of DNA in each well, except as noted
below.
The Bio-Rad digital PCR system measures only endpoint
droplet fluorescence after all thermal cycling is completed. Thus
measured copy numbers might vary with the number of
amplification cycles used. For perfectly efficient amplification, a
single starting template would be amplified to the probe
concentration (250 nM) in 25 cycles, resulting in signal saturation.
To test the sensitivity of ddPCR to variation in cycle number and
to determine the optimal cycle number, test samples consisting of
plasmid (Fig. 2) or diluted, infected CD4 cells (Fig. S1) were
divided between three plates and cycled for 30, 40 or 50 cycles. No
significant changes were noted within this range. When the cycle
number was reduced to 20, the signal was completely eliminated
and no positive events were detected (data not shown). Subsequent
experiments were conducted using 40 PCR cycles.
To compare the accuracy of the HIV DNA quantification by
the two methods, stored PBMC samples (N=156) were analyzed
by both qPCR and ddPCR in triplicate. Samples were collected
from 24 patients at varying times during the first 6 months
following initiation of combination antiretroviral therapy (cART).
Measurements made by the two methods were linearly correlated
(Pearson R2 = 0.64), with a slope statistically indistinguishable from
unity (est. slope = 0.9860.08, Fig. 3). The correlation weakened at
lower copy numbers, and was not significant in the bottom tertile
(,230 copies per million PBMC).
Although levels of cell-associated HIV DNA are affected much
less by cART than is plasma HIV RNA, levels of residual HIV
DNA after several years of suppressive therapy are significantly
lower than during the first 6 months of therapy [20]. To evaluate
the precision of the digital PCR assay for samples collected from
patients on suppressive cART, PBMC samples (N= 146) from 3
distinct cohorts of patients were analyzed by ddPCR in triplicate
(Fig. 4). All patients were enrolled in studies requiring undetectable
viremia for at least 6 months. To assess the intrinsic accuracy of
the assay, pol and 2-LTR concentrations estimated within each
well were compared with the result averaged over triplicate wells
(Fig. S2 (a)). As expected, assay variability increased at lower
template concentration.
The specific mathematical form of this expected variation
among replicates is a binomial distribution
P N,nð Þ~
XN
n~0
N!
(N{n)!n!
 
1{e{mð Þn e{mð ÞN{n
Where P N,nð Þ is the probability that n of N droplets is positive and
m is the unknown template concentration before droplet formation.
In the limit of large N, this is approximated well by a Poisson
distribution. To test the hypothesis that detected templates are
Poisson distributed, the data were grouped into bins of width 0.1
log10 bins. The average coefficient of variation (C.V.) was
computed for each bin, and these averages were fitted by linear
regression (Fig. S2 (b)). The C.V. increased as the template
number to the 0.4860.07, consistent with a Poisson distribution.
To determine the distribution of assay noise in the qPCR assay,
plasmid or infected cell templates were serially diluted and
evaluated by qPCR with 10–12 replicates per sample (Fig. S3). For
template frequencies above 300 copies/million cells, correspond-
ing to a cycle threshold (CT) of 32 or fewer, the coefficient of
variation was low and independent of template concentration. In
this regime, the error distribution was approximately log-normal
with a standard deviation of 0.07 log10 copies.
At low template concentrations, random sampling of templates
occurs in qPCR, suggesting that the noise distribution should
become Poissonian in this regime. However, the ratio between the
copy number estimated per well and number of events N in the
Poisson distribution might not be the expected value, primarily
because the absolute copy number estimates rely on a (potentially
skewed) standard curve. The coefficient of variation was therefore
fitted to a model that assumed log-normal errors at high copy
number and Poisson distribution at low copy number (Fig. S3 (a)).
The increase in assay noise is consistent with Poissonian variation,
but the constant ratio exceeded the expected value over 10-fold
(maximum likelihood estimate = 236). Thus the qPCR assay
errors are comparable to the ddPCR errors at 23-fold higher
template concentration.
Next, the limit of detection of the ddPCR assay was evaluated.
The assay used in previous experiments loaded DNA from
approximately 500,000 cells into each triplicate, making detection
of templates present at fewer than 2 copies per million theoretically
impossible. To differentiate the intrinsic detection limit for the
ddPCR assay from this loading limit, a serial dilution of DNA
isolated from infected CD4 cells into uninfected PBMC DNA was
tested with a number of replicate wells that increased as the
reciprocal of the template number to a maximum of 36 wells
Figure 1. PCR Inhibition by background host DNA. Plasmids
containing pol (pNL4-3) or the 2-LTR junction sequence were spiked
into varying amounts of cellular background (salmon sperm) DNA prior
to droplet formation. The figure shows the measured copy number as a
percentage of the value expected from A260/A280 absorptivity of the
plasmid. Loading of over 1.5 mg of DNA per well greatly reduced the
measured copy number for all samples tested. Above 3 mg/well, droplet
formation was also inhibited (not shown).
doi:10.1371/journal.pone.0055943.g001
Measurement of HIV DNA by Droplet Digital PCR
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(Fig. 5). This allowed detection of both pol and 2-LTR circles at
frequencies of 0.7 copies per 106 cells.
All experiments described above used the same conserved
primer-probe set. Because of the high diversity of HIV genomes in
vivo, even regions that are relatively well conserved may vary in
some patients. Mismatches in the primers or the probes might
reduce the efficiency of amplification or probe hydrolysis without
eliminating the signal completely. In this scenario, qPCR may
substantially underestimate the true template copy number. This
problem can be circumvented by using patient-specific primers
and probes if HIV DNA sequence data are available, but this
approach is cumbersome [19].
To determine how ddPCR measurements would be affected by
sequence variation, samples were selected from a large cohort with
pol sequence data available. Among these 84 patients, 21 had
variations in the sequence complementary to the probe and over
half had variations at one or both primer sites. Four patients with
the most extreme mismatches between pol sequence and the
consensus primer/probe set were evaluated by both ddPCR and
qPCR using both patient-specific and consensus primers and
probes (Fig. 6). With qPCR, the use of consensus sets resulted in an
underestimate of pol concentration by 10 to 100-fold in 3 of the 4
patients. In the fourth patient, no template was detected at all
using consensus primers. When the same samples were analyzed
by ddPCR, the underestimate (in log10 pol c/10
6 cells) was
reduced in all cases, with an average 57% reduction.
Discussion
Several applications of digital PCR reported recently have
demonstrated that the high accuracy possible in theory can be
practically realized with a variety of clinical specimens
[4,7,21,22,23,24]. The need for a standardized, accurate assay
for persistent HIV DNA in infected patients led us to develop a
ddPCR assay for HIV DNA. This need is especially relevant to
investigate the latent HIV reservoir. The extremely rare HIV
DNA targets studied here pose unique challenges, and the
theoretical performance of both qPCR and ddPCR assays might
diverge from results obtained in analysis of clinical specimens for
such rare targets. We therefore optimized and characterized the
performance of both assays in detail.
Figure 2. Values measured by digital PCR do not vary with cycle number. Plasmid templates were emulsified into droplets and thermally
cycled for 30 to 50 cycles before analysis. No significant differences in measured pol (A) or 2-LTR (B) copy numbers were observed over this range of
cycling times. No positive events were observed after 20 cycles (not shown). Similar results were obtained using dilutions of infected CD4+ T cells into
uninfected PBMC (Fig. S.1). Error bars indicate the observed standard deviation between wells.
doi:10.1371/journal.pone.0055943.g002
Figure 3. Correlation of ddPCR and qPCR measurements. (a) Pol copy numbers measured by ddPCR and qPCR were significantly correlated
(Pearson R2 = 0.64, slope= 0.9860.08). The correlation weakened at low copy numbers, primarily due to a rapid increase in the variance of the qPCR
assay (Fig. S3 (a)). For copy numbers measured in the bottom tertile (,230 HIV DNA copies/106 cells) by ddPCR, the correlation was not significant
(R2 = 0.08, P = 0.12). In the central tertile, the correlation was weak but significant (R2 = 0.15, P = 0.03). In the top tertile, the correlation was strong
(R2 = 0.53, P,0.0001). (b) 2-LTR copy numbers measured by both methods were significantly but weakly (R2 = 0.14, P = 0.002) correlated.
doi:10.1371/journal.pone.0055943.g003
Measurement of HIV DNA by Droplet Digital PCR
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To maximize assay sensitivity, the maximum input DNA
concentration was established first. Inhibition of the PCR reaction
occurred abruptly when over 1.5 mg of extracted DNA was loaded
into the 20 ml reaction input. (Fig. 1) Although this inhibition was
expected, the exact mechanism is unclear. Droplet formation was
noticeably impaired at loading concentrations as low as 3 mg per
20 ml, suggesting that chemical reactions at the oil-water interface
of the emulsion may play a role.
The number of amplification cycles used had no discernible
effect on measured values of either pol or 2-LTR, provided that at
least 30 cycles were used. (Fig. 2 and Fig. S1) Twenty PCR cycles,
which would yield only 1.5 nM amplicon from a single template
with perfect amplification efficiency, produced no discernible
change in fluorescence above background. The robustness of event
counts with varying cycle number justifies the use of endpoint
fluorescence, which is necessary with the digital droplet platform
used in this study (Bio-Rad QX-100). Real-time monitoring of
fluorescence during thermal cycling is possible with other
hardware configurations, but we could not evaluate whether this
would this would provide any benefit due to system hardware
limitations.
Because identical primers and probes were used for the two
assays, we expected both assays to provide similar information. To
determine the correlation and bias of the two methods, 156 clinical
samples were tested by both assays. Values measured by the two
techniques were strongly correlated (R2 = 0.64), and there was no
discernible bias between the two methods. Therefore both assays
indeed provide similar measurements, and the principal difference
between them is the structure and magnitude of noise.
The primary motivation for developing a ddPCR assay for HIV
DNA was the prospect of reducing the noise observed in the qPCR
Figure 4. Precision of ddPCR versus qPCR. Samples of DNA (N= 156) isolated from the PBMC of patients during the first 6 months of cART were
analyzed by both qPCR and ddPCR in triplicate. The reproducibility was higher for both the pol (a) and 2-LTR (b) targets. Because the noise and
stochasticity of all assays varies with copy number, the relative precision was assessed by averaging the coefficient of variation within small bins
(Fig. S2 (b)). The average coefficient of variation was 4-fold lower by ddPCR (Fig. S4 (b)) and 20-fold lower for 2-LTR (Fig. S4 (c)). An imputed value of 6
copies/106 cells, equivalent to 1 copy/well, was used for wells in which no template was detected.
doi:10.1371/journal.pone.0055943.g004
Figure 5. Assay limit of detection and quantification. CD4 cells
infected in vitro were serially diluted into a background of PBMC DNA.
The number of replicate wells was increased from 3 to 36 in proportion
to the dilution, allowing accurate measurement below one copy per 106
cells. The shaded area indicates concentrations below the theoretical
limit of detection for a single well.
doi:10.1371/journal.pone.0055943.g005
Figure 6. Effect of sequence variation. Patient isolates with
previously determined pol sequences that differ from the consensus
primer/probe set in at least two positions were analyzed by ddPCR and
by qPCR. Both assays were conducted in parallel using the mismatched
consensus primer/probe set and a patient-specific matched primer/
probe set. Use of consensus primers and probe resulted in an
underestimate of copy number by one to two log10 by qPCR, with
complete loss of detection in the extreme case of 5 total mismatched
bases. The underestimate was largely mitigated (mean 57% reduction in
log10 copy number change) by ddPCR in all cases. These 4 cases reflect
the most extreme mismatches observed in 84 patients, suggesting that
sequence variation is unlikely to significantly impact ddPCR assay
results in clinical studies. All samples analyzed were HIV-1 subtype B.
doi:10.1371/journal.pone.0055943.g006
Measurement of HIV DNA by Droplet Digital PCR
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assay. Three different methods were used to determine assay
accuracy. As an initial test, plasmids or patient samples were
serially diluted and evaluated using a large number of replicates.
(Figs. 4 and S3(b)) Next, the variance among replicates was
compared using the 156 samples assayed in parallel by both
methods. (Fig. 3) Finally, an independent set of 214 clinical
samples drawn from 3 different cohorts was analyzed by ddPCR,
and the variance among triplicate wells for each sample was
evaluated. (Fig. S2 (a))
All three methods led to the conclusion that ddPCR was
substantially more precise for HIV template frequencies below 300
copies/106 cells. For ddPCR, the variance among replicates
approached the mean over replicates. This is consistent with the
hypothesis that Poissonian variation due to random sampling is the
principal source of noise in ddPCR assays of rare templates
[4,8,25]. The variance also increased linearly with the mean for
the qPCR assay, but the magnitude of this variance was higher by
an average of 4-fold for pol (Fig. S4 (b)) and by 20-fold for 2-LTR
(Fig. S4 (c)). This suggests that a Poissonian process produces
accuracy-limiting noise in the qPCR assay, as well, but the process
is evidently not simply random sampling of template by pipetting
into the 96-well reaction plate.
It is unclear why the real-time 2-LTR assay was so much less
precise. It had previously been noted that pre-heating samples
improved the performance of the 2-LTR assay (data not shown).
This procedure, which has been speculated to remove secondary
structure, was used consistently here. Samples were not digested
with a restriction enzyme prior to real-time analyses, so it is
possible that the restriction digest used prior to digital PCR had
the inadvertent benefit of removing inhibitory secondary structure
in episomal DNA.
The term ‘‘limit of detection’’ is used in various ways depending
on the context. The definition that seems most applicable in
typical HIV research applications is simply the template concen-
tration below which detection will usually not occur at levels
distinguishable from background noise. In the triplicate format
used predominantly here, this limit is between 3 and 4 copies per
million cells, depending on the number of droplets formed. A far
more mathematically demanding definition used in clinical
chemistry requires that the 95% confidence intervals of an
undetected sample not overlap with the 95% confidence interval
of a sample at the limit of detection [26]. By this definition, the
limit of detection would be 14 copies per million cells. This latter
definition might indeed be more appropriate for clinical diagnostic
use in which disregarding a ‘‘zero’’ value could lead to
inappropriate clinical management, but that is not the intended
use here. The behavior of the assay near the limit of detection is
consistent with Poisson statistics, and the limit of detection can
therefore be calculated by any definition desired.
As shown in Fig. 5, the limit of detection can be further
decreased by increasing the number of replicates analyzed. Note,
however, that false positive background events preclude arbitrary
improvement in the limit of detection. False positive events in no-
template control wells, while infrequent as a percentage of all
droplets analyzed, were observed regularly. In general, these were
not distinguishable from true positives based on fluorescence data.
(Figs. S6 and S7) Retrospective analysis of over 500 no-template
control wells estimated an average of between 0.1 and 0.4 false
positive events per well, and somewhat higher rates have been
reported previously [8]. This average rate appeared to fluctuate
over periods of several weeks (data not shown), but the source of
false positives is unclear. Based on this background rate, our
absolute limit of detection has varied from 0.7 to 3 copies per
million cells.
One important limitation of the Bio-Rad QX-100 system is the
dynamic range. Because the system works by counting positive
reactions among approximately 15,000 droplets per sample well,
the dynamic range is limited to between 4 and 5 log10 [8]. Thus
HIV DNA copy numbers per cell cannot be measured in a single
well by ddPCR. Either the HIV target is too scarce to detect or the
host gene used for normalization (here RPP30) will is too
abundant to quantify without saturation. This limitation can by
circumvented by combining dilution series with ddPCR. The assay
described here required used a single 10-fold dilution (in triplicate)
to address this problem. Other implementations of digital PCR
have a different dynamic range. It is therefore difficult to
generalize about the linear dynamic range of our digital PCR
assay, since this could easily be extended with additional dilutions.
The ddPCR work described here used the Bio-Rad QX-100
droplet digital PCR system exclusively, and our results may not
apply to alternative implementations of digital PCR. The current
QX-100 system suffers from two limitations that significantly
impact the HIV DNA assay reported here. The first is the
unexplained false positive events mentioned above. In addition,
categorization of events as positive or negative based on measured
fluorescence values is not trivial. The default thresholds set by Bio-
Rad’s QuantaSoft analysis software result in some obviously
incorrect calls. Re-analysis of raw fluorescence data using custom
software corrected most of these errors, but false positive could not
be completely eliminated. (Figs. S6 and S7) Whether these
important system limitations are intrinsic features of the QX-100
platform or can be eliminated with future improvements to the
system software, device hardware, disposable components or assay
protocols is currently unclear.
Despite these limitations, droplet digital PCR was found to be a
practical method for highly accurate measurement of HIV DNA
targets in clinical specimens. Existing qPCR assays for pol and 2-
LTR HIV DNA were readily adapted to digital PCR without
modification of primer/probe sets, re-optimization of thermal
cycling parameters or changes in clinical sample processing.
Unexpectedly, ddPCR also proved more robust to target sequence
variation. Most importantly, the improved accuracy and precision
resulted in reliable quantification of proviral and episomal HIV
DNA targets well below the limit of quantification of qPCR. These
features make ddPCR particularly well suited to measurement of
the size of the HIV latent reservoir and suggest that this assay
could prove useful for clinical studies aimed at eradication of HIV
from infected patients.
Supporting Information
Figure S1 Values measured by digital PCR do not vary
with cycle number. DNA isolated from CD4+ T cells infected
in vitro was serially diluted, emulsified into droplets and thermally
cycled for 30 to 50 cycles before analysis. No significant differences
in measured pol or 2-LTR copy numbers were observed over this
range of cycling times. No positive events were observed after 20
cycles (not shown). False-positive events in no-template control
wells were also unaffected by cycle number (data not shown).
(PDF)
Figure S2 Poissonian noise among ddPCR replicates. (a)
Copy numbers estimated from each well are plotted versus the
average over triplicate wells for 370 clinical samples. In addition to
the 156 samples described All patients were on cART and were
enrolled in studies requiring at least 6 months of suppressed
plasma viremia (,50 HIV RNA copies/ml). Wells with no events
detected are excluded from the plot in (a), but not from the
analysis in (b). Red dashed lines show the expected value plus or
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minus one standard deviation, assuming the data are Poisson
distributed. (b) To more rigorously assess whether the data in (a)
are consistent with a Poisson distribution, the coefficient of
variation was computed for each well (black dots), and errors were
averaged over bins of width 0.2 log10 (blue squares). Observed
average errors (solid black regression line) were smaller than the
Poissonian prediction (dashed violet line) by 0.1560.10 log10, but
this difference was not statistically significant.
(PDF)
Figure S3 Noise in qPCR assay. The cycle threshold (CT),
which measures the number of PCR cycles required for template
amplification, varies only slightly (median 0.07 cycles) at low CT
values (higher target amounts). Templates consisting of either
plasmid or samples from an HIV-infected patient were diluted into
HIV- cellular DNA background to determine the effect of input
copy number on assay variability. (a) As the number of input
template copies decreases below about 300 copies/106 cells, the
standard deviation of the CT value among replicate wells increases
rapidly. Poissonian sampling noise (dotted line) imposes a
theoretical minimum on the assay noise (dotted line), but the
observed noise (dashed line) is much larger (least-squares fit = 236
larger). (b) The corresponding number of pol copies N estimated
based on the best fit to a standard curve (N~
41:6{CT
3:65
)
illustrates the large variance compared to ddPCR (Fig. S2(a)),
even for plasmid templates.
(TIF)
Figure S4 The ddPCR assay is more precise, particu-
larly for 2-LTR circles. Samples isolated from the PBMC of
infected patients were assayed by both methods. To compare the
precision throughout the tested range, the C.V. was averaged over
bins as in Fig. S2 (b). All 370 clinical samples analyzed by ddPCR
in Figs. 3 and S2 (a) were included, despite the fact that qPCR data
was only available for the 156 samples shown in Fig. 3. (a) For
both methods and both targets, the C.V. increases with a slope
statistically that is not significantly different from K, the expected
value for Poisson-distributed noise (dashed line). Trend lines
computed independently for the four assays did not have
distinguishable slopes. Therefore, in order to estimate the average
relative precision, maximum likelihood fits shown assume the K
exponent. The offset between the trend lines indicates the relative
precision. (b) For the pol target, ddPCR is 4-fold more precise. (c)
The precision improvement is much greater for the 2-LTR target,
with an average 20-fold improvement over qPCR.
(PDF)
Figure S5 Triage classification of events. Raw fluores-
cence data were first filtered to eliminate events consistent with
irregular droplet size (‘‘rain’’ and ‘‘hail’’). The remaining events
were analyzed according to the algorithm shown. First, the largest
droplet clusters were identified. In most cases, positive events were
rare and nearly all events were associated with droplets that were
negative in both fluorescence channels. Significant clusters were
then approximated with a binormal distribution, and the
probability of each droplet was determined for each of these
distributions. Events that were highly unlikely within any of the
binormal distributions were classified as ambiguous. Finally,
independent assortment of the duplexed targets was used to
eliminate events with an unlikely combination of fluorescence
amplitudes. Restriction enzymes used in this study were always
expected to cut between the duplexed amplicons, so the number of
positive events in each channel was assumed independent. This
was used to identify spurious double-positive events.
(PDF)
Figure S6 Sample dot-plots illustrate threshold ambi-
guities in ddPCR. Raw fluorescence values from a single well
are shown. Default thresholds set by Bio-Rad QuantaSoft analysis
software (version 1.1) are shown as colored rectangles, and the
corresponding event counts in each quadrant are shown. (a)
‘‘Rain’’ and ‘‘hail’’ extend outward from the central peak of dual-
negative events, but these are easily distinguished from true
positive events by cluster analysis. (b) The pattern is similar to (a),
but the sparseness of hail complicates its discrimination from true
positive events. The one dual-positive event called by QuantaSoft
can be eliminated by the assumption of independent assortment.
(PDF)
Figure S7 Sample false positives in ddPCR. Positive events
called in no-template control wells may reflect erroneous calls by
the default thresholding algorithm (a), but most false-positive
events are well separated from true negative events and thus
cannot be identified mathematically (b).
(PDF)
Table S1 PCR Primers and Probes.
(DOCX)
Table S2 Summary of Clinical Characteristics for
Unblinded Patients. The 156 samples analyzed by both qPCR
and ddPCR were drawn from ACTG5248, during the first 6
months of treatment.
(DOCX)
Acknowledgments
Gratitude is extended to Adriana Andrade, Steven Deeks, Hiroyu Hatano,
Daniel Kuritzkes, David Margolis, and Robert Siliciano, who provided
clinical samples. The authors would like to acknowledge the support of the
UCSD/VMRF CFAR Genomics Core. The views expressed in this article
are those of the authors and do not necessarily reflect the position or policy
of the Department of Veterans Affairs (VA), Veterans Health Administra-
tion, Office of Research and Development, or the United States
government.
Author Contributions
Conceived and designed the experiments: MCS SML SER DDR.
Performed the experiments: SML TL SG VHT. Analyzed the data:
MCS SML DDR. Contributed reagents/materials/analysis tools: SG
VHT CAS CHW DDR. Wrote the paper: MCS SML SER CHW DDR.
References
1. Higuchi R, Fockler C, Dollinger G, Watson R (1993) Kinetic PCR analysis: real-
time monitoring of DNA amplification reactions. Biotechnology (N Y) 11: 1026–
1030.
2. Vogelstein B, Kinzler KW (1999) Digital PCR. Proc Natl Acad Sci U S A 96:
9236–9241.
3. Pohl G, Shih Ie M (2004) Principle and applications of digital PCR. Expert Rev
Mol Diagn 4: 41–47.
4. Sanders R, Huggett JF, Bushell CA, Cowen S, Scott DJ, et al. (2011) Evaluation
of digital PCR for absolute DNA quantification. Anal Chem 83: 6474–6484.
5. Whale AS, Huggett JF, Cowen S, Speirs V, Shaw J, et al. (2012) Comparison of
microfluidic digital PCR and conventional quantitative PCR for measuring copy
number variation. Nucleic Acids Res 40: e82.
6. White RA 3rd, Blainey PC, Fan HC, Quake SR (2009) Digital PCR provides
sensitive and absolute calibration for high throughput sequencing. BMC
Genomics 10: 116.
7. White RA 3rd, Quake SR, Curr K (2011) Digital PCR provides absolute
quantitation of viral load for an occult RNA virus. J Virol Methods 179: 45–50.
Measurement of HIV DNA by Droplet Digital PCR
PLOS ONE | www.plosone.org 7 April 2013 | Volume 8 | Issue 4 | e55943
8. Hindson BJ, Ness KD, Masquelier DA, Belgrader P, Heredia NJ, et al. (2011)
High-throughput droplet digital PCR system for absolute quantitation of DNA
copy number. Anal Chem 83: 8604–8610.
9. Piatak M Jr, Saag MS, Yang LC, Clark SJ, Kappes JC, et al. (1993) High levels
of HIV-1 in plasma during all stages of infection determined by competitive
PCR. Science 259: 1749–1754.
10. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, et al. (1995) Rapid
turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature
373: 123–126.
11. Caliendo AM (1995) Laboratory methods for quantitating HIV RNA. AIDS
Clin Care 7: 89–91, 93, 96.
12. Mendel I, Clotteau L, Lambert S, Buffet-Janvresse C (1995) Hepatitis C virus
infection in an HIV-positive population in Normandy: antibodies, HCV RNA
and genotype prevalence. J Med Virol 47: 231–236.
13. Everall IP, Hudson L, al-Sarraj S, Honavar M, Lantos P, et al. (1995) Decreased
expression of AMPA receptor messenger RNA and protein in AIDS: a model for
HIV-associated neurotoxicity. Nat Med 1: 1174–1178.
14. Wang J, Huang SY, Choudhury I, Leibowitz MJ, Stein S (1995) Use of a
polyethylene glycol-peptide conjugate in a competition gel shift assay for
screening potential antagonists of HIV-1 Tat protein binding to TAR RNA.
Anal Biochem 232: 238–242.
15. Wu-Baer F, Lane WS, Gaynor RB (1995) The cellular factor TRP-185 regulates
RNA polymerase II binding to HIV-1 TAR RNA. EMBO J 14: 5995–6009.
16. Saksela K, Stevens CE, Rubinstein P, Taylor PE, Baltimore D (1995) HIV-1
messenger RNA in peripheral blood mononuclear cells as an early marker of risk
for progression to AIDS. Ann Intern Med 123: 641–648.
17. Daly TJ, Doten RC, Rusche JR, Auer M (1995) The amino terminal domain of
HIV-1 Rev is required for discrimination of the RRE from nonspecific RNA.
J Mol Biol 253: 243–258.
18. Butler SL, Hansen MS, Bushman FD (2001) A quantitative assay for HIV DNA
integration in vivo. Nat Med 7: 631–634.
19. Althaus CF, Gianella S, Rieder P, von Wyl V, Kouyos RD, et al. (2010) Rational
design of HIV-1 fluorescent hydrolysis probes considering phylogenetic variation
and probe performance. J Virol Methods 165: 151–160.
20. Strain MC, Gunthard HF, Havlir DV, Ignacio CC, Smith DM, et al. (2003)
Heterogeneous clearance rates of long-lived lymphocytes infected with HIV:
intrinsic stability predicts lifelong persistence. Proc Natl Acad Sci U S A 100:
4819–4824.
21. Yung TK, Chan KC, Mok TS, Tong J, To KF, et al. (2009) Single-molecule
detection of epidermal growth factor receptor mutations in plasma by
microfluidics digital PCR in non-small cell lung cancer patients. Clin Cancer
Res 15: 2076–2084.
22. Lun FM, Chiu RW, Allen Chan KC, Yeung Leung T, Kin Lau T, et al. (2008)
Microfluidics digital PCR reveals a higher than expected fraction of fetal DNA
in maternal plasma. Clin Chem 54: 1664–1672.
23. Fan HC, Blumenfeld YJ, El-Sayed YY, Chueh J, Quake SR (2009) Microfluidic
digital PCR enables rapid prenatal diagnosis of fetal aneuploidy. Am J Obstet
Gynecol 200: 543 e541–547.
24. Tadmor AD, Ottesen EA, Leadbetter JR, Phillips R (2011) Probing individual
environmental bacteria for viruses by using microfluidic digital PCR. Science
333: 58–62.
25. Kreutz JE, Munson T, Huynh T, Shen F, Du W, et al. (2011) Theoretical design
and analysis of multivolume digital assays with wide dynamic range validated
experimentally with microfluidic digital PCR. Anal Chem 83: 8158–8168.
26. Linnet K, Kondratovich M (2004) Partly nonparametric approach for
determining the limit of detection. Clin Chem 50: 732–740.
Measurement of HIV DNA by Droplet Digital PCR
PLOS ONE | www.plosone.org 8 April 2013 | Volume 8 | Issue 4 | e55943
